APA (7th ed.) Citation

J, B., NS, T., LJ, H., S, O., A, B., T, B., . . . P, G. (2026). The impact of next generation sequencing studies on the diagnosis of BAP1 inactivated melanocytic tumors. Human pathology, 172, 106103. https://doi.org/10.1016/j.humpath.2026.106103

Chicago Style (17th ed.) Citation

J, Braat, et al. "The Impact of Next Generation Sequencing Studies on the Diagnosis of BAP1 Inactivated Melanocytic Tumors." Human Pathology 172 (2026): 106103. https://doi.org/10.1016/j.humpath.2026.106103.

MLA (9th ed.) Citation

J, Braat, et al. "The Impact of Next Generation Sequencing Studies on the Diagnosis of BAP1 Inactivated Melanocytic Tumors." Human Pathology, vol. 172, 2026, p. 106103, https://doi.org/10.1016/j.humpath.2026.106103.